Three MTPConnect projects - the Industry Mentoring Network in STEM (IMNIS), the Medical Device Partnering Program (MDPP) and Asialinks Business - have received funding from the MTPConnect Project Fund Program. IMNIS and MDPP were part of the 2016 round of the program and Asialinks is a new project.

MTPConnect's Chair Dr Bronwyn Evans supported the launch of the MTPConnect WA Node in partnership with the Western Australian Government and the University of Western Australia at the Harry Perkins Institute and Centre for Medical Research.

MTPConnect's CEO Sue MacLeman talks to Healthcare IT about the recent announcement of the amazing innovations of the MTPConnect-delivered, Department of Health's $10 million BioMedTech Horizons program.

The article focuses on the team behind the Biopen, one of the 11 selected participants who have received funding from the MTPConnect-delivered Department of Health's $10 million BioMedTech Horizons program.

MTPConnect and BioPacific Partners has jointly launched an exciting new initiative to assist Australian medical technology and pharmaceutical companies to better prepare and position themselves to engage successfully with multinational companies.

MTPConnect CEO Sue MacLeman talks to Innovation Australia about creating gender diversity within the tech and innovation sector or lose global competitiveness in this critical arena on International Women's Day.

MTPConnect has released new sector metrics that show jobs supported by the MTP sector increased by 10 per cent to 62,000 from 2015 to 2016, and that manufacturing exports are up by 30 per cent to $5.2 billion.

Managed by MTPConnect, the $5m BioMedTech Horizons program will be managed by MTPConnect, the medical technologies and pharmaceuticals industry growth centre. MTPConnect chief executive Sue MacLeman spoke to The Australian, saying that 3D anatomical printing and precision medicine had been identified for the first share of funding because Australia punched above its weight in those areas.

Our General Manager of Education, Skills and Events Dr Melanie Thomson about the training that will save pharmaceutical manufacturing businesses time and money by allowing employees to transfer basic skills between companies.

The Medical Technologies and Pharmaceuticals Industry Growth Centre (MTPConnect) announced at the recent AusBiotech annual conference that it would provide A$7.4 million (US$5.6 million) of funding over two years for 14 national projects in the med-tech, biotech and pharmaceutical sector, with the Australian government injecting more funding into its life sciences sector to help it become more globally competitive in commercializing products.

Growing investment in medical technology and pharmaceutical innovation is set to fire a new pipeline of high-impact ventures into Australia that have been hiding in the corridors of universities waiting to be commercialised. This week, non-profit organisation MTPConnect announced it will inject $7.4 million into 14 medtech, biotech and pharmaceutical projects over the next two years. The funding will be matched by a further $32 million from industry partners under MTP Connect’s project fund program.

Our CEO Sue MacLeman comments on the recent Federal Government response to the Review of Medicines and Medical Devices Regulation in this article highlighting Johnson & Johnson's potential commercialisation of two winning inventions from a hackathon earlier this month.